Supplementation with @mg/d folate resulted in reduced plasma Hcy ( -@ vs -@ and @m , respectively , P < @ ) , HOMA-B ( -@ vs @ and @ , respectively , P < @ ) , serum hs-CRP ( -@ vs -@ and @g/l , respectively , P < @ ) and plasma MDA concentrations ( -@ vs -@ and @m , respectively , P < @ ) compared with folate-@ and placebo groups .